|
Rodney Young joined StemCells, Inc. in September 2005. He is responsible for the financial and administrative functions of the Company, as well as for managing investor relations and the Company's overall relationship with the financial community. Mr. Young was formerly Chief Financial Officer and a Director of Extropy Pharmaceuticals, Inc., a private pharmaceutical company focused on developing drugs for pediatric indications, where he was responsible for all financial and administrative functions. Before joining Extropy, Mr. Young was Managing Director and head of healthcare corporate finance in Europe for SG Cowen Securities, and prior to that, he spent more than a decade at Lehman Brothers, where he was a senior investment banker in both the healthcare and mergers & acquisitions groups. Mr. Young earned his BA and MBA degrees from the University of Chicago. | 